Schedule 13G ownership disclosure

ADVERUM BIOTECHNOLOGIES INC

Common Stock, $0.0001 par value per share · CUSIP: 00773U207

Event date: 2025-12-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLSP, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLSP, L.L.C.

    Shares: 0.00 · Class: 0.0%

  • Frazier Life Sciences X, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLS X, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLS X, L.L.C.

    Shares: 0.00 · Class: 0.0%

  • Frazier Life Sciences XI, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLS XI, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLS XI, L.L.C.

    Shares: 0.00 · Class: 0.0%

  • Frazier Life Sciences XII, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLS XII, L.P.

    Shares: 0.00 · Class: 0.0%

  • FHMLS XII, L.L.C.

    Shares: 0.00 · Class: 0.0%

  • James N. Topper

    Shares: 0.00 · Class: 0.0%

  • Patrick J. Heron

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001231919-25-000590
Form type
SCHEDULE 13G/A
Filer
Adverum Biotechnologies, Inc.
CIK
CIK 1501756
Filed
Dec 09, 2025
Reporting period
Dec 09, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub